LifeSpan Licenses DrugTarget Database to Undisclosed Pharma

genomeweb
360dx

LifeSpan Licenses DrugTarget Database to Undisclosed Pharma

Aug 23, 2004

NEW YORK, Aug. 23 (GenomeWeb News) - LifeSpan BioSciences said today that it has licensed its DrugTarget database to an undisclosed pharmaceutical company, marking the 50th database license the company has issued.

To read the full story....

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

ABRF Speakers Outline Disaster Prep for Core Facilities
Rainbow Genomics, UCLA Partner to Offer Exome Dx in Asia
Single-Cell Study Finds Chromatin Epigenetic Variability Rises with Age
Meridian Bioscience's Q2 Revenues Up 4 Percent, Beat Estimates
Roche Q1 Diagnostics Revenues Rise 5 Percent, Liat Sales Surge
Radboud UMC, NimaGen Partner to Develop Targeted Sequencing Kits

The Scan

Getting It Early

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

Food Bugs to Meet Sequencers

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

From Ancient Bathrooms

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

This Week in Nature

In Nature this week: ash dieback disease fungal genome, and more.

Main menu